AC Immune (ACIU) Receivables - Net (2015 - 2024)

AC Immune (ACIU) has 6 years of Receivables - Net data on file, last reported at $28.4 million in Q3 2024.

• On a quarterly basis, Receivables - Net changed N/A year-over-year to $28.4 million in Q3 2024; TTM through Sep 2024 was $28.4 million, a N/A change from a year earlier, with the FY2023 full-year figure at $16.7 billion, changed N/A from the prior year.
• Receivables - Net for Q3 2024 stood at $28.4 million, down from $16.7 billion in the prior quarter.
• Over the last five years, Receivables - Net for ACIU reached as high as $16.7 billion in Q4 2023 and fell as low as $7.5 million in Q4 2021.
• Historically, Receivables - Net has averaged $3.4 billion across 4 years, with a median of $31.0 million in 2020.
• Across the five-year window, Receivables - Net surged 118.96% in 2020 and plunged 88.73% in 2021, its largest moves.
• Year by year, Receivables - Net stood at $66.4 million in 2020, then plunged by 88.73% to $7.5 million in 2021, then soared by 222868.09% to $16.7 billion in 2023, then slumped by 99.83% to $28.4 million in 2024.
• Per Business Quant data, the three most recent Receivables - Net figures were $28.4 million in Q3 2024, $16.7 billion in Q4 2023, and $7.5 million in Q4 2021.